Search for: "ASTRAZENECA LP" Results 21 - 40 of 159
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Dec 2015, 11:54 am by Dennis Crouch
  Patents in his portfolio include US Patent Numbers 6,331,400, 6,771,291, 7,353,199, 7,996,259, 8,335,713, 8,412,570, 8,417,567, 8,423,399, 8,442,860, 8,589,222, 8,650,076, 8,768,760, 8,781,890 and 8,996,398.[8] = = = = = [1] US patent Application No. 10/868,312, claim number 24. [2] See 1 Chisum on Patents section 1.02. [3] In re Russell, 48 F.2d 668, 669 (CCPA 1931)(indexing the names in directories and dictionaries). [4] AstraZeneca LP v. [read post]
8 Dec 2015, 2:22 pm by Ben Vernia
  AstraZeneca LP and Cephalon Inc. paid the United States $26.7 million and $4.3 million, respectively, in separate settlements for allegedly underpaying rebates owed under the Medicaid Drug Rebate Program. [read post]
9 Sep 2015, 6:11 am by Mary Jane Wilmoth
The Department of Justice announced settlements in the following False Claims Act lawsuits: AstraZeneca and Cephalon to Pay $46.5 Million and $7.5 Million, Respectively, for Allegedly Underpaying Rebates Owed Under Medicaid Drug Rebate Program AstraZeneca LP has agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program, the Justice… [read post]
8 Apr 2015, 3:41 pm by Sean Wajert
AstraZeneca Pharm., LP, 634 F.3d 1352, 1362 (11th Cir. 2011) (“Several considerations shape the physician’s medical judgment, including both individual patient concerns and drug-specific information regarding the propriety of a drug’s use for treatment of a patient’s given condition . . . [read post]
27 Feb 2015, 5:02 am by Mary Jane Wilmoth
AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
AstraZeneca LP et al. was filed under seal on behalf of the federal government in October 2010 by former AstraZeneca employees Paul DiMattia and F. [read post]
17 Nov 2014, 9:59 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
13 Nov 2014, 5:00 am
Courtesy of Mike Imbroscio of Covington (who was on the winning team) today’s post is about a very satisfying Cymbalta win – not only did warning causation fail under the learned intermediary rule, but the warning for the drug was held adequate as a matter of law. [read post]
26 Oct 2014, 9:17 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
23 Jun 2014, 12:57 pm by Schachtman
ITERATIVE DISJUNCTIVE SYLLOGISM Basic propositional logic teaches that the disjunctive syllogism (modus tollendo ponens) is a valid argument, in which one of its premises is a disjunction (P v Q), and the other premise is the negation of one of the disjuncts: P v Q ~P­­­_____ ∴ Q See Irving Copi & Carl Cohen Introduction to Logic at 362 (2005). [read post]
3 May 2014, 8:56 am by Schachtman
After a long winter, the cherry trees are finally managing to blossom. [read post]
8 Dec 2013, 8:02 pm by Patent Docs
Aurobindo Pharma Ltd. et al. 3:13-cv-07298; filed December 3, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
13 Nov 2013, 9:14 pm by Patent Docs
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed and remanded a decision of noninfringement by the District Court for the District of New Jersey with respect to U.S. [read post]
27 Oct 2013, 9:55 pm by Patent Docs
Lupin Ltd. et al. 3:13-cv-06315; filed October 23, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Astrazeneca LP; KBI-E Inc.; Pozen, Inc. [read post]
25 Oct 2013, 3:56 am by Lorene Park
In the court’s view, this circumstantial evidence of a “pattern of antagonism” raised an inference of retaliation and was enough to support her Title VII claim (Brangman v AstraZeneca, LP). [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
14 Aug 2013, 1:57 pm
We’ve already provided our readers with our list of the testimony (trial and deposition) of the seemingly ubiquitous plaintiff’s expert Dr. [read post]